---
title: "康乃德生物制药 (CNTB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CNTB.US/norm.md"
symbol: "CNTB.US"
name: "康乃德生物制药"
parent: "https://longbridge.com/zh-CN/quote/CNTB.US.md"
datetime: "2026-05-20T20:31:32.473Z"
locales:
  - [en](https://longbridge.com/en/quote/CNTB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNTB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNTB.US/norm.md)
---

# 康乃德生物制药 (CNTB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3431 | -0.2695 | -0.3087 | -0.2324 | -0.1856 |
| ROE | -183.43% | -124.16% | -108.59% | -66.90% | - |
| 营业收入 | 169000.00 | 0.0000 | 16000.00 | 48000.00 | - |
| 净利润 | -19.40M | -15.11M | -17.20M | -12.90M | -10.27M |
| 营业利润 | -19.61M | -15.53M | -17.68M | -13.42M | -11.45M |
| 毛利率 | 100.00% | - | 100.00% | 100.00% | - |
| 净利率 | -11478.11% | - | -107500.00% | -26872.92% | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 60.07M | 56.08M | 67.36M | 82.72M | 92.69M |
| 权益乘数 | 1.41 | 1.34 | 1.22 | 1.16 | 1.12 |
| 每股净资产 | 0.6797 | 0.7438 | 0.9926 | 1.28 | 1.50 |
| 资产周转率 | 0.0031 | 0.0008 | - | 0.0193 | - |
| 现金及短投 | 46.03M | 44.34M | 54.78M | 71.77M | 84.00M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 4.36M | 4.46M | 4.67M | 4.88M | 4.83M |
| 净债务 | -45.34M | -43.65M | -54.00M | -70.90M | -83.06M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -16.00M | -11.25M | -17.41M | -12.59M | -9.96M |
| 投资现金流 | 6.00M | 10.98M | 14.35M | 5.13M | -20.64M |
| 融资现金流 | 17.62M | 715000.00 | 215000.00 | 161000.00 | 2000.00 |
| 自由现金流 | -11.14M | -5.19M | -11.12M | -7.63M | - |
| 现金流充裕率 | - | -70312.50% | -51194.12% | -4155.45% | -12295.06% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -16000.00 | -34000.00 | -303000.00 | -81000.00 |